Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin.
about
The p85 regulatory subunit of phosphoinositide 3-kinase down-regulates IRS-1 signaling via the formation of a sequestration complexConserved proximal promoter elements control repulsive guidance molecule c/hemojuvelin (Hfe2) gene transcription in skeletal musclePostnatal muscle modification by myogenic factors modulates neuropathology and survival in an ALS mouse modelReciprocal inhibition between MyoD and STAT3 in the regulation of growth and differentiation of myoblastsmRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle massNeuroendocrine-like differentiation of non-small cell lung carcinoma cells: regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1Fibroblast growth factor inducible 14 (Fn14) is required for the expression of myogenic regulatory factors and differentiation of myoblasts into myotubes. Evidence for TWEAK-independent functions of Fn14 during myogenesisAkt promotes BMP2-mediated osteoblast differentiation and bone developmentDifferential regulation of Shc adaptor proteins in skeletal muscle, spinal cord and forebrain of aged rats with sensorimotor impairmentL6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathwayAmphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE bindingSMAD signaling drives heart and muscle dysfunction in a Drosophila model of muscular dystrophyConstitutive expression of insulin receptor substrate (IRS)-1 inhibits myogenic differentiation through nuclear exclusion of Foxo1 in L6 myoblastsSelective signaling by Akt2 promotes bone morphogenetic protein 2-mediated osteoblast differentiation.Exercise-induced skeletal muscle remodeling and metabolic adaptation: redox signaling and role of autophagy.Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regenerationSatellite cells and the muscle stem cell nicheTIMP3: a physiological regulator of adult myogenesis.Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice.The multifunctional role of IGF-1 in peripheral nerve regeneration.Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications.Invited Review: Autocrine/paracrine IGF-I and skeletal muscle adaptation.Suppression of protein kinase C theta contributes to enhanced myogenesis in vitro via IRS1 and ERK1/2 phosphorylationThe intrauterine growth restriction phenotype: fetal adaptations and potential implications for later life insulin resistance and diabetes.Permissive roles of phosphatidyl inositol 3-kinase and Akt in skeletal myocyte maturationAKT and PAX3-FKHR cooperation enforces myogenic differentiation blockade in alveolar rhabdomyosarcoma cellSerum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factorsInsulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions.Pancreatic cancer cell-derived IGFBP-3 contributes to muscle wastingThe FoxO transcription factors and metabolic regulation.Intrauterine growth restriction increases fetal hepatic gluconeogenic capacity and reduces messenger ribonucleic acid translation initiation and nutrient sensing in fetal liver and skeletal muscleDistinct actions of Akt1 and Akt2 in skeletal muscle differentiation.PKN2 and Cdo interact to activate AKT and promote myoblast differentiation.The myogenic kinome: protein kinases critical to mammalian skeletal myogenesis.JAK-STAT pathway and myogenic differentiation.Bone is Not Alone: the Effects of Skeletal Muscle Dysfunction in Chronic Kidney Disease.Molecular effects of supraphysiological doses of doping agents on health.Ubiquitin C-Terminal Hydrolase L1 regulates myoblast proliferation and differentiation.Overexpression of LARGE suppresses muscle regeneration via down-regulation of insulin-like growth factor 1 and aggravates muscular dystrophy in mice.
P2860
Q24310123-160BA0DF-0E3A-4CBA-A023-1BBF067563E2Q24569886-5B560F39-4460-482C-86D7-39862BB15FF1Q27324722-121E9E22-F678-4E8E-AE90-E063FA14F517Q28204258-B625FDEF-5B26-4D87-BA30-D44553386925Q28239563-2E37346C-E657-4D21-8C14-5B403DA04151Q28283027-4CD69362-BD64-40A6-945E-5C5BBD67339BQ28294844-7E542561-F352-4638-B2EE-4AC62CCD1EC9Q28511143-64815DF3-DC16-40C1-9E21-64A35427B3F4Q28564997-52EC6FDD-CB36-4A51-9219-2A7C2C1D46E9Q28577479-C9FA1031-23CC-4895-8466-601192F1B507Q28579193-2B384DCC-5ABC-49CC-BF78-FD632F3AE561Q30498086-82E665F0-EF81-495F-811C-E73A5DB829A9Q31032454-59E6F5A7-1C51-444E-AE06-1BC76BF94E42Q33627269-60DC5F95-A10E-46AD-97D9-EED9D1E57EECQ33722890-867B0D39-9405-4DF1-A34D-FBE4C16B8BE6Q33735493-D542AC6A-7F69-407A-BEAF-36B7C028EC2FQ33816665-4F2BEA11-5C0A-4387-96CE-7C64637B6927Q34072911-23C54668-9F26-41C2-BC70-DF8303FF8FFCQ34162346-9C4AA969-781D-4A06-B011-EFA52D9D34FCQ34312093-DA26FA1E-A87B-463F-897E-3C2B84444015Q34322871-2F9A28C6-2BFB-4818-8F1E-F72ACBA2ACFDQ34787113-7F742A1F-6381-4763-815F-CBAC55FD8E56Q34993218-E6BD90C5-3551-401D-8CEE-9714241DFC21Q35551159-F26D82F7-E358-4A2D-B32D-E449F08D7540Q35796563-A1677CB7-EFAB-4C00-8CE7-52B7B0FEA95CQ35881962-C9783891-82ED-4FD9-BCC7-07917BBF44CDQ36315910-A4209698-42FC-4691-9BB3-B64E201863DEQ36325079-38FE9078-5D21-4157-9329-6D9CB1707E0CQ36629298-036B898E-8DA5-4450-AD6A-611938450CC8Q36686835-37005BF3-CD3C-4BE3-871D-DF0C8CF6B590Q37005651-CFBEFA68-C7B4-4D22-81E8-0DC2DD3B3F4EQ37244654-3432C2D5-CC3D-42B0-B207-696AA5A8D316Q37361165-DBD30127-FEA1-4684-8A02-0FFDAF53B72FQ37465852-B4456B17-F2DD-4421-BBBF-EE80C8B1934DQ37929319-5C7D4C03-7CBF-4A9F-A0C8-C644A82C7164Q38140909-1C2B06B1-B5F0-4DE9-9AB3-A2FEEBFCB7ABQ38359416-6CC186A0-C2EB-4274-A2C5-AB62DE517A23Q38383101-82276EAE-2B8B-4C5F-A10D-8246A12A4026Q38627051-78CE461D-4D69-4304-8BAF-5414821D4A79Q39005429-219851FE-C2E7-416E-9681-CC05BA80A665
P2860
Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Insulin-like growth factor-med ...... gnaling pathways and myogenin.
@en
type
label
Insulin-like growth factor-med ...... gnaling pathways and myogenin.
@en
prefLabel
Insulin-like growth factor-med ...... gnaling pathways and myogenin.
@en
P2093
P356
P1476
Insulin-like growth factor-med ...... gnaling pathways and myogenin.
@en
P2093
E M Wilson
J L Cappalonga
J Tureckova
P304
39264-39270
P356
10.1074/JBC.M104991200
P407
P577
2001-08-10T00:00:00Z